Top Markets
Coin of the day
Defence Therapeutics Inc. Defence Therapeutics Inc.

Defence Therapeutics Inc.

DTC
Classifica tra le azioni #28133
Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a... Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a biotechnology company founded in 2017. This firm focuses on pioneering biological and biosimilar therapeutic solutions for both cancer and infectious diseases. A cornerstone of its approach is the exclusive ACCUM™ technology, engineered to precisely and safely transport vaccine antigens or antibody-drug conjugates (ADCs) directly to their intended cellular targets. The company's development efforts span several key areas: novel dendritic cell vaccines for various cancers, protein-based vaccines addressing COVID-19 and other infectious ailments, and specialized antibody-drug conjugate products aimed at different cancer types. Defence Therapeutics Inc. adopted its current name in March 2020, having previously operated as Accum Therapeutics Inc.
Prezzo delle azioni
$0.37430781
Ultima sincronizzazione: 2026-08-19
Capitalizzazione di mercato
$28.37M
Variazione (1 giorno)
2.00%
Variazione (1 anno)
-13.46%
Paese
CA
Scambia Defence Therapeutics Inc. (DTC)

Categoria

Cronologia dei frazionamenti azionari per Defence Therapeutics Inc. (DTC)
L’azione Defence Therapeutics Inc. (simbolo: DTC) ha subito un totale di 0 frazionamenti.
L’ultimo frazionamento è avvenuto il Aug 20, 2026.
Una quota di DTC acquistata prima di Aug 20, 2026 equivale oggi a 0 quote di DTC.
Elenco dei frazionamenti azionari
Anno Frazionamento Moltiplicatore Moltiplicatore cumulativo
Non abbastanza dati per le date fornite.
Frazionamenti azionari di aziende simili o concorrenti
Azienda Numero di frazionamenti azionari Moltiplicatore cumulativo Il paese
1 x2
US
0 -
US
0 -
NL
1 x3
AU
0 -
CH